Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesOsteopore Ltd

Osteopore Ltd

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
0.003 AUD 0.00(0%)
Last update at 2026-11-11T01:06:00Z
VOLUME
103000
Market Cap
2.08M

Momentum Score

…

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Osteopore Ltd develops bioresorbable 3D-printed scaffolds for bone regeneration in craniofacial, dental and orthopaedic applications. Long-term growth may be supported by adoption of resorbable alternatives, rising surgical demand from aging populations and expanded clinical use; the proprietary scaffold platform could address unmet reconstructive needs if the company scales manufacturing and builds clinical evidence.
Key risks are regulatory and reimbursement uncertainty, slow surgeon adoption and competition from larger device makers, manufacturing scale-up and execution risk, and further financing needs.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
2.93M
Revenue Per Share
0.01
Gross Profit TTM
2.36M
Debt / Equity
-0.12
ROE
-487.52%
Net Debt
-0.43M
ROCE
973.71%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.72M -3.33M -4.83M -4.20M -3.62M
Net income -3.72M -3.35M -4.87M -4.22M -3.93M
Selling general administrative - 2.21M 2.03M 4.52M 4.20M
Selling and marketing expenses - 1.48M 1.91M 1.01M 0.50M
Gross profit 1.62M 2.37M 1.64M 1.36M 1.10M
Reconciled depreciation - 0.53M 0.46M 0.22M 0.23M
Ebit -2.67M -2.82M -4.81M -4.17M -3.60M
Ebitda -1.92M -2.34M -4.35M -3.96M -3.38M
Depreciation and amortization 0.75M 0.48M 0.46M 0.22M 0.23M
Operating income -2.67M -2.82M -4.93M -4.17M -3.60M
Other operating expenses 5.73M 5.63M 7.14M 6.17M 5.23M
Interest expense 0.28M 0.43M 0.02M 0.02M 0.02M
Tax provision - 0.02M 0.04M 0.00M 0.00M
Interest income - 0.43M 0.01M 0.02M 0.02M
Net interest income - -0.43M -0.01M -0.02M -0.02M
Income tax expense 0.00M 0.02M 0.04M 0.02M 0.31M
Total revenue 3.06M 2.81M 2.22M 1.78M 1.40M
Total operating expenses 4.29M 5.19M 6.10M 5.75M 4.93M
Cost of revenue 1.44M 0.45M 0.58M 0.42M 0.30M
Total other income expense net -1.05M -0.51M 0.10M -0.02M -0.02M
Net income from continuing ops - -3.35M -4.87M -4.20M -3.62M
Net income applicable to common shares - -3.35M -4.87M -4.20M -3.62M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.77M 3.32M - 3.62M 6.01M
Intangible assets - 0.46M - - -
Other current assets 0.55M 0.65M -1.11M 0.71M 0.29M
Total liab 4.50M 2.88M - 1.51M 0.63M
Total stockholder equity -1.73M 0.43M - 2.11M 5.37M
Other current liab 1.32M 0.06M - 0.07M 0.03M
Common stock 34.31M 32.60M - 27.01M 26.07M
Capital stock - - - 27.01M 26.07M
Retained earnings -21.72M -17.96M - -10.90M -7.95M
Cash 0.63M 0.64M 1.11M 2.16M 4.93M
Cash and equivalents - - - 0.01M -
Total current liabilities 3.05M 2.77M - 1.48M 0.56M
Net debt -0.43M 0.69M -1.11M -2.09M -4.82M
Short term debt 0.11M 1.22M - 0.05M 0.08M
Short long term debt total 0.20M 1.33M - 0.07M 0.11M
Other stockholder equity - - - -0.20M -12.74M
Property plant equipment - - - 0.47M 0.59M
Total current assets 2.59M 2.53M - 3.15M 5.42M
Net tangible assets - - - 2.05M 5.37M
Short term investments - - - - 0.20M
Net receivables 1.05M 0.86M - 0.87M 0.40M
Inventory 0.36M 0.38M - 0.28M 0.20M
Accounts payable 1.62M 1.49M - 1.37M 0.45M
Accumulated other comprehensive income -14.32M -14.21M - -14.00M -12.74M
Non currrent assets other - - - - 0.18M
Non current assets total 0.18M 0.78M - 0.47M 0.59M
Capital lease obligations - - - 0.07M 0.11M
Long term debt total - - - 0.03M 0.07M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.01M -0.01M -0.06M -0.19M
Change to liabilities - - - 0.87M -0.27M
Total cashflows from investing activities -0.01M -0.01M -0.01M -0.06M -0.19M
Net borrowings - - 2.22M -0.05M -0.49M
Total cash from financing activities 2.67M 2.63M 3.58M 0.84M -0.49M
Change to operating activities - - - -0.38M -0.11M
Net income -3.72M -3.35M -4.87M -4.22M -3.62M
Change in cash -0.01M -0.48M -0.22M -3.20M -4.50M
Begin period cash flow 0.63M 1.11M 1.33M 4.53M 9.03M
End period cash flow 0.63M 0.64M 1.11M 1.33M 4.53M
Total cash from operating activities -2.56M -3.09M -3.74M -4.00M -3.81M
Issuance of capital stock - 3.12M 2.69M 0.94M -
Depreciation 0.75M 0.53M 0.46M 0.22M 0.23M
Change to inventory 0.02M -0.10M 0.00M -0.08M -0.05M
Change to account receivables -0.43M -0.32M -0.26M -0.43M -0.06M
Sale purchase of stock - -0.11M -0.17M -0.05M 0.00M
Other cashflows from financing activities -0.06M -0.33M -0.05M -0.05M -0.04M
Change to netincome - - - 0.00M 0.08M
Capital expenditures 0.01M 0.01M 0.01M 0.06M 0.19M
Change in working capital -0.06M -0.73M 0.09M -0.02M -0.53M
Stock based compensation - 0.18M 0.54M - -
Other non cash items 0.47M 0.29M 0.04M 4.00M 3.40M
Free cash flow -2.57M -3.10M -3.74M -4.06M -4.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OSX
Osteopore Ltd		 -
-%		 0.00 - - 0.71 15.36 1.47 -2.20
RMD
Resmed Inc		 0.60
1.77%		 34.47 21.77 19.57 8.49 5.53 5.50 14.10
FPH
Fisher & Paykel Healthcare Corporation Ltd		 -0.15
0.38%		 39.29 55.56 48.54 9.91 12.92 11.78 33.96
ANN
Ansell Ltd		 0.45
0.97%		 46.95 21.27 22.73 2.99 2.16 2.24 12.03
NAN
Nanosonics Ltd		 0.05
1.80%		 2.83 49.17 78.12 4.33 4.02 3.64 24.30

Profile*

Osteopore Ltd

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

2 Tukang Innovation Grove #09-06/07, Singapore, Singapore, 618305

61 2 8072 1400

https://www.osteopore.com

Name Title Year Born
Mr. Kei Wei Leong Exec. Chairman 1976
Mr. Khoon Seng Goh Chief Exec. Officer NA
Dr. Jing Lim COO & CTO NA
Ms. Deborah Ho AGIA, B.Com. Company Sec. 1988
Mr. Kei Wei Leong Executive Chairman 1976
Dr. Jing Lim CEO & CTO NA
Mr. Khoon Seng Goh Global Marketing Director NA
Ms. Shu Ning Voon Financial Controller NA
Ms. Kellie Davis Joint Company Secretary NA
Mr. Kei Wei Leong Executive Chairman 1976

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…